نتایج جستجو برای: steatotic hepatitis

تعداد نتایج: 127357  

Journal: :European review for medical and pharmacological sciences 2003
I Grattagliano P Portincasa P Caraceni V O Palmieri M Domenicali M Bernardi G Palasciano

Fatty accumulation per se does not appear to affect liver function; however, interest has recently renewed to fatty liver because of the clinical relevance of non alcoholic steato-hepatitis (NASH) and for the increased risk of post-transplant failure in grafted livers with steatosis. Clinical and experimental studies have doubtless demonstrated that oxidative stress ensues in steatotic livers. ...

2010
Wellington Andraus Gabriela Freitas Pereira de Souza Marcelo Ganzarolli de Oliveira Luciana B. P. Haddad Ana Maria M. Coelho Flavio Henrique Galvão Regina Maria Cubero Leitão Luiz Augusto Carneiro D’Albuquerque Marcel Cerqueira Cesar Machado

BACKGROUND Steatosis is currently the most common chronic liver disease and it can aggravate ischemia-reperfusion (IR) lesions. We hypothesized that S-nitroso-N-acetylcysteine (SNAC), an NO donor component, can ameliorate cell damage from IR injury. In this paper, we report the effect of SNAC on liver IR in rats with normal livers compared to those with steatotic livers. METHODS Thirty-four r...

Journal: :gastroenterology and hepatology from bed to bench 0
akram safaei afsaneh arefi oskouie seyed reza mohebbi mostafa rezaei-tavirani mohammad mahboubi maryam peyvandi

metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. in cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (nafld) and non-alcoholic steatotic hepatitis (nash) the  liver  does not function thoroughly due to long-term damage. unfortunately the early detection of cirrhosis, hcc, na...

2014
SHI-WEI ZHOU MAN ZHANG MIN ZHU

Simple hepatic steatosis is the early stage of non‑alcoholic fatty liver disease and is recognized as a benign process. Previous studies show that glucagon‑like peptide‑1 has great potential in improving hepatic steatosis. Recent data have revealed that inhibiting autophagy exacerbates lipid accumulation in hepatocytes. Therefore, the present study aimed to determine the effects of liraglutide ...

2015
Akitoshi Matsuda Naohisa Kuriyama Hiroyuki Kato Akihiro Tanemura Yasuhiro Murata Yoshinori Azumi Masashi Kishiwada Shugo Mizuno Masanobu Usui Hiroyuki Sakurai Shuji Isaji

UNLABELLED Activated protein C (APC) has cytoprotective effects on liver ischemia-reperfusion injury (IRI). However, it is unclear whether APC is beneficial in steatotic liver IRI. We compared the cytoprotective effects of APC in nonsteatotic and steatotic liver IRI. METHODS Mice fed either normal diets (ND mice) or high fat diets (HF mice), were treated with APC or saline (control) and were ...

2013
Reza F. Saidi

Improvements in surgical techniques, immunosuppression, and post-transplantation patient care have led to the optimization of liver transplantation outcomes. However, the waiting list for liver transplantation is increasing at a greater pace. The large gap between the growing pool of patients waiting for liver transplantation and the scarcity of donor organs has fueled efforts to maximize exist...

Journal: :Journal of Cellular and Molecular Medicine 2017

2017
Shaowei Li Terumi Takahara Masayuki Fujino Yasuyuki Fukuhara Toshiro Sugiyama Xiao-Kang Li Shiro Takahara

Steatosis has a low tolerance against ischemia-reperfusion injury (IRI). To prevent IRI in the steatotic liver, we attempted to elucidate the protective effect of astaxanthin (ASTX) in the steatotic liver model by giving mice a methionine and choline-deficient high fat (MCDHF) diet. Levels of lipid peroxidation and apoptosis, the expression of inflammatory cytokines and heme oxygenase (HO)-1, i...

2016
Akram Safaei Afsaneh Arefi Oskouie Seyed Reza Mohebbi Mostafa Rezaei-Tavirani Mohammad Mahboubi Maryam Peyvandi Farshad Okhovatian Mona Zamanian-Azodi

Metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. In cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH) the liver does not function thoroughly due to long-term damage. Unfortunately the early detection of cirrhosis, HCC, NAFL...

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2005
Daniel Y Hung Gerhard A Siebert Ping Chang Frank J Burczynski Michael S Roberts

Nonalcoholic fatty liver disease is the most common of all liver diseases. The hepatic disposition [(3)H]palmitate and its low-molecular-weight metabolites in perfused normal and steatotic rat liver were studied using the multiple indicator dilution technique and a physiologically based slow diffusion/bound pharmacokinetic model. The steatotic rat model was established by administration of 17 a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید